Biogen Inc (BIIB)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$165.68

Buy

$181.50

arrow-up$1.60 (+0.93%)

Prices updated at 13 Dec 2025, 00:57 EST

Prices minimum 15 mins delay

Prices in USD

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$175.08 - $171.27
	$185.17 - $110.04
	-
	25,540.87m
	15.87
	-
	1,781,471
	1.40
	1,629,136.56
	0.50
	169.52m
	US09062X1037
	10.97
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.